Information was received from a surgeon who is not required to complete form 3500a.The device was not returned for evaluation.Device history records for the lot were reviewed and found to be conforming requirements at the time of manufacture.Independent lab testing has confirmed that the residue is non-toxic.Zimmer has done testing that shows that the residue can be removed using a soft cloth moistened with water or isopropyl alcohol.Biocompatibility testing has determined that there exists a negligible risk to the patient associated with the sticky bag occurrence.The device was used for treatment.The femoral component was packaged with a raw material lot of polyethylene bags that was previously identified as having the potential to adhere to highly polished surfaces, which may leave a residue and in some cases a portion of polyethylene on the device.Many factors have been identified that lead to the sticky bag occurrence, such as the size of the implant, the time of the year the product was packaged and the material formulation of the polyethylene bags.This issue has been previously investigated and as part of corrective action, a new supplier for the polyethylene bags has been selected and testing completed to ensure thermal reliability and stability of the new bags.This mdr was identified during an internal retrospective review to meet reporting requirements and therefore is being filed retrospectively.Device not returned.
|